Sara Lodi, PhD
Associate Professor
Boston University School of Public Health
Dept of Biostatistics

PhD, London School of Hygiene & Tropical Medicine
MSc, University of Southampton

Pronouns: she/her/hers



Sara Lodi is an Associate Professor of Biostatistics at the Boston University School of Public Heath. She obtained her PhD in Medical Statistics at the London School of Hygiene and Tropical Medicine in 2009, UK. Her research focuses on causal inference methods for observational studies using big data, methods for causal inference to improve the statistical analysis of clinical trials, and the reconciliation of results from clinical trials and observational studies. She leads cutting edge research that focuses on the translation of methodologic advancements in causal inference into actionable findings for real world public health research questions, mainly in the areas of infectious diseases (HIV, hepatitis C, tuberculosis) and substance use disorder. She has published many articles on behalf of large international collaborations of HIV cohorts such as CASCADE, COHERE and the HIV-CAUSAL, and HepCAUSAL collaborations. She’s been an instructor for both BS851 Applied Statistics in Clinical Trials and BS807 Applied Causal Inference in Health Research.

Diversity, Equity, Inclusion and Accessibility

I have incorporated DEIJ into my activities in multiple ways:
-I have participated in University-wide DEIJ training
-I have completed additional DEIJ training for search committees
-I participate in discussions of DEIJ topics that arise at each department faculty meeting
-I collaborate with a diverse group of investigators with a range of backgrounds and cultures
-I teach and mentor a diverse group of students and trainees
-I completed the title IX mandatory training


Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers - 1/2
09/15/2017 - 08/31/2023 (Subcontract PI)
The Regents of the University of California, San Francisco NIH NIAAA
5U01AA026223-06

Personnel Agreement for Research Services of Sara Lodi
06/01/2022 - 05/31/2023 (PI)
Ann Arbor VA Medical Center


Dynamic Strategies for the clinical management of HIV disease
06/01/2020 - 05/31/2023 (Subcontract PI)
President and Fellows of Harvard College dba Harvard T.H. Chan School of Public Health NIH NIAID
5R37AI102634-10

MOUD Comparative Effectiveness Study
07/01/2021 - 04/30/2023 (Subcontract PI)
Boston Medical Center Corporation NIH NIDA
1R01DA054268-02

Population-Level Effects of Increasing PrEP Uptake on HIV and Bacterial STIs
07/26/2019 - 06/30/2022 (Subcontract PI)
Harvard Pilgrim Health Care Inc NIH NIAID
1R21Al143386-01A1

Causal inference for the treatment and management of multidrug-resistant tuberculosis
12/01/2020 - 08/31/2021 (Key Person / Mentor)
NIH/National Institute of Allergy & Infectious Diseases
1F31AI157333-01

Stigma, Risk Behaviors and Health care among HIV-Infected Russian People Who Inject Drugs
09/01/2020 - 08/31/2021 (Subcontract PI)
Boston Medical Center Corporation NIH NIDA
5R00DA041245-05

Stigma, Risk Behaviors and Health care among HIV-Infected Russian People Who Inject Drugs
09/01/2018 - 08/31/2019 (Subcontract PI)
Boston Medical Center Corporation NIH NIDA
4R00DA041245-03

Forecasting the Impact of Correction-based MOUD in Massachusetts (FICOMM)
12/01/2017 - 11/30/2018 (Subcontract PI)
Boston Medical Center Corporation OffNtlDrugCtrlPolicy




Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Lodi S, Klein M, Rauch A, Epstein R, Wittkop L, Logan R, Rentsch CT, Justice AC, Touloumi G, Berenguer J, Jarrin I, Egger M, Puoti M, D'Arminio Monforte A, Gill J, Salmon Ceron D, van Sighem A, Linas B, van der Valk M, Hernán MA. Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co-infection. J Int AIDS Soc. 2022 Dec; 25(12):e26048. PMID: 36562643; PMCID: PMC9784654; DOI: 10.1002/jia2.26048;
     
  2. Turcinovic J, Schaeffer B, Taylor BP, Bouton TC, Odom-Mabey AR, Weber SE, Lodi S, Ragan EJ, Connor JH, Jacobson KR, Hanage WP. Understanding Early Pandemic Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in a Medical Center by Incorporating Public Sequencing Databases to Mitigate Bias. J Infect Dis. 2022 Nov 11; 226(10):1704-1711. PMID: 35993116; PMCID: PMC9452097; DOI: 10.1093/infdis/jiac348;
     
  3. Rodriguez CA, Lodi S, Horsburgh CR, Bastard M, Hewison C, Huerga H, Khan M, Khan PY, Khan U, Oyewusi L, Padayachee S, Mitnick CD, Franke MF. Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion. PLoS One. 2022; 17(11):e0276457. PMID: 36355658; PMCID: PMC9648724; DOI: 10.1371/journal.pone.0276457;
     
  4. Fang Y, Lodi S, Hughes TM, Frank E, Sen S, Bohnert ASB. Work Hours and Depression in U.S. First-Year Physicians. N Engl J Med. 2022 Oct 20; 387(16):1522-1524. PMID: 36260798; PMCID: PMC9807271; DOI: 10.1056/NEJMc2210365;
     
  5. Miller AP, Fatch R, Lodi S, Marson K, Emenyonu N, Kekibiina A, Beesiga B, Chamie G, Muyindike WR, Hahn JA. Unhealthy alcohol use and intimate partner violence among men and women living with HIV in Uganda. BMC Public Health. 2022 Oct 10; 22(1):1886. PMID: 36217183; PMCID: PMC9552439; DOI: 10.1186/s12889-022-14295-2;
     
  6. Forman LS, Lodi S, Fatch R, Emenyonu NI, Adong J, Ngabirano C, Jacobson KR, Gerona R, Reckers AR, Gandhi M, Muyindike WR, Hahn JA. Agreement Between Measures of Adherence to Isoniazid Preventive Therapy Among People With HIV in Uganda. Open Forum Infect Dis. 2022 Oct; 9(10):ofac516. PMID: 36320196; PMCID: PMC9605696; DOI: 10.1093/ofid/ofac516;
     
  7. Barocas JA, Savinkina A, Lodi S, Epstein RL, Bouton TC, Sperring H, Hsu HE, Jacobson KR, Schechter-Perkins EM, Linas BP, White LF. Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study. Clin Infect Dis. 2022 Aug 24; 75(1):e1112-e1119.View Related Profiles. PMID: 34499124; PMCID: PMC8522427; DOI: 10.1093/cid/ciab779;
     
  8. Lodi S, Chamie G, HahnJ. Statistical Analysis Plan for the Drinkers' Intervention to Prevent Tuberculosis (DIPT Study). arXiv preprint. 2022. View Publication
  9. Lodi S, Rossi SL, Bendiks S, Gnatienko N, Lloyd-Travaglini C, Vetrova M, Toussova O, Bushara N, Blokhina E, Krupitsky E, Ekstrand ML, Lioznov D, Samet JH, Lunze K. Correlates of Intersectional HIV and Substance Use Stigma Affecting People with HIV and Substance Use in St. Petersburg, Russia. AIDS Behav. 2022 Aug 02. PMID: 35916947
     
  10. Hook K, Sereda Y, Rossi S, Koberna S, Vetrova MV, Lodi S, Lunze K. HIV, substance use, and intersectional stigma: Associations with mental health among persons living with HIV who inject drugs in Russia. AIDS Behav. 2022 Aug 01. PMID: 35913589
     
Showing 10 of 74 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 74 publications over 14 distinct years, with a maximum of 20 publications in 2022

YearPublications
20041
20104
20114
20125
20134
20146
20151
20163
20173
20182
20193
20203
202115
202220


Projected Long-Term Impact of the COVID-19 Pandemic on Outcomes Associated With Hepatitis C Virus

Infection Disease Advisor 10/7/2021
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

HIV
Causal inference
Clinical trials
Hepatitis C
Substance Use Disorder
Contact for Mentoring:

801 Massachusetts Avenue
Boston MA 02118
Google Map

617.638.5160
Download vCard

Lodi's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (202) concept(s)
_
Media Mentions
_
Co-Authors
See all (35) people
_
Similar People
See all (60) people
_
Same Department
Search Department